公司资料
Aldeyra Therapeutics, Inc. 股价、新闻与催化剂
- 股票代码:
- ALDX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.56 USD (0.00%)
收盘价
最后更新: 2026年8月17日
98.9M USD
市值
股价为何变动
As of Aug 17, 2026, ALDX was little changed and closed at $1.56. No new same-company headline was identified in the current news window.
公司概览
业务概览
Aldeyra Therapeutics is a biotechnology company focused on inflammation, ophthalmology, and immune-mediated disease. Its story is built around therapies for conditions where inflammation plays a major role.
所在地与行业分类
Aldeyra is headquartered in the United States and listed on NASDAQ. It sits in specialty immunology and ophthalmology biotechnology.
商业模式特征
The company depends on clinical data, regulatory progress, and the ability to develop a focused pipeline in challenging inflammatory diseases. Investors usually watch efficacy, safety, and approval milestones.
生物医药行业定位
Aldeyra occupies a niche inflammation-and-eye-disease position within biotech. The stock is catalyst-sensitive because a narrow number of data events can meaningfully shift the story.
未来催化剂
- Aldeyra’s catalysts are reproxalap and the dry-eye / ophthalmology regulatory path, where the next step can materially move the stock. The company is still very event-driven.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。